Ovid Therapeutics Inc (OVID)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 0 | 718 | 132 | 6,272 | 130 |
| Gross Profit | N/A | 718 | 132 | 6,272 | 130 |
| Operating Expenses | 17,846 | 13,011 | 12,655 | 11,345 | 12,680 |
| Operating Income | -17,846 | -12,293 | -12,523 | -5,073 | -12,550 |
| Other Income | 858 | 21,956 | 365 | 389 | 2,315 |
| Pre-tax Income | -16,988 | 9,663 | -12,158 | -4,684 | -10,235 |
| Net Income Continuous | -16,988 | 9,663 | -12,158 | -4,684 | -10,235 |
| Net Income | $-16,988 | $9,663 | $-12,158 | $-4,684 | $-10,235 |
| EPS Basic Total Ops | -0.12 | 0.14 | -0.17 | -0.06 | -0.14 |
| EPS Basic Continuous Ops | -0.12 | 0.14 | -0.17 | -0.07 | -0.14 |
| EPS Diluted Total Ops | -0.12 | 0.14 | -0.17 | -0.06 | -0.14 |
| EPS Diluted Continuous Ops | -0.12 | 0.14 | -0.17 | -0.07 | -0.14 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.06 | -0.17 | -0.06 | -0.14 |
| EBITDA(a) | $-17,811 | $-12,276 | $-12,507 | $-4,974 | $-12,409 |